Difference between revisions of "Chapter 8"
From GARDGuide
Line 15: | Line 15: | ||
** [[Guide8.4.8|8.4.8 Sampling and Analysis Plan (SAP)]] | ** [[Guide8.4.8|8.4.8 Sampling and Analysis Plan (SAP)]] | ||
* [[Guide8.5|8.5 Overview of Monitoring Approaches]] | * [[Guide8.5|8.5 Overview of Monitoring Approaches]] | ||
− | ** 8.5.1 Implementation Considerations | + | ** [[Guide8.5.1|8.5.1 Implementation Considerations]] |
*** 8.5.1.1 Health and Safety | *** 8.5.1.1 Health and Safety | ||
*** 8.5.1.2 Freshwater, Estuarine and Saline Receiving Environments | *** 8.5.1.2 Freshwater, Estuarine and Saline Receiving Environments | ||
*** 8.5.1.3 Source/Near-Field/Far-Field Monitoring | *** 8.5.1.3 Source/Near-Field/Far-Field Monitoring | ||
− | ** 8.5.2 Discharge monitoring | + | ** [[Guide8.5.2|8.5.2 Discharge monitoring]] |
− | ** 8.5.3 Reference Comparisons | + | ** [[Guide8.5.3|8.5.3 Reference Comparisons]] |
*** 8.5.3.1 Upstream-Downstream | *** 8.5.3.1 Upstream-Downstream | ||
*** 8.5.3.2 Gradient Monitoring Design | *** 8.5.3.2 Gradient Monitoring Design | ||
*** 8.5.3.3 Reference Condition Design | *** 8.5.3.3 Reference Condition Design | ||
− | ** 8.5.4 Exposure Assessment | + | ** [[Guide8.5.4|8.5.4 Exposure Assessment]] |
*** 8.5.4.1 Data Collection | *** 8.5.4.1 Data Collection | ||
*** 8.5.4.2 Comparison to Chemical Guidelines | *** 8.5.4.2 Comparison to Chemical Guidelines | ||
*** 8.5.4.3 Mercury Biomagnification | *** 8.5.4.3 Mercury Biomagnification | ||
*** 8.5.4.4 Environmental Fate | *** 8.5.4.4 Environmental Fate | ||
− | ** 8.5.5 Effects Assessment | + | ** [[Guide8.5.5|8.5.5 Effects Assessment]] |
*** 8.5.5.1 Bioavailability | *** 8.5.5.1 Bioavailability | ||
*** 8.5.5.2 Toxicity Testing | *** 8.5.5.2 Toxicity Testing | ||
Line 35: | Line 35: | ||
*** 8.5.5.4 Investigation of Causation | *** 8.5.5.4 Investigation of Causation | ||
*** 8.5.5.5 The Value of Integrated Assessments | *** 8.5.5.5 The Value of Integrated Assessments | ||
− | ** 8.5.6 Risk Characterisation | + | ** [[Guide8.5.6|8.5.6 Risk Characterisation]] |
− | ** 8.5.7 Uncertainty | + | ** [[Guide8.5.7|8.5.7 Uncertainty]] |
− | ** 8.5.8 Monitoring and Management | + | ** [[Guide8.5.8|8.5.8 Monitoring and Management]] |
* [[Guide8.6|8.6 Monitoring Specifics]] | * [[Guide8.6|8.6 Monitoring Specifics]] | ||
** 8.6.1 Sampling | ** 8.6.1 Sampling |
Revision as of 03:38, 13 December 2007
8.0 Chapter 8: Monitoring (Peter Chapman)
- 8.1 Introduction
- 8.2 Objectives of Monitoring
- 8.3 The ARD Monitoring Approach
- 8.3.1 Risk Based Framework
- 8.3.2 Monitoring Components
- 8.4 Problem Formulation
- 8.5 Overview of Monitoring Approaches
- 8.5.1 Implementation Considerations
- 8.5.1.1 Health and Safety
- 8.5.1.2 Freshwater, Estuarine and Saline Receiving Environments
- 8.5.1.3 Source/Near-Field/Far-Field Monitoring
- 8.5.2 Discharge monitoring
- 8.5.3 Reference Comparisons
- 8.5.3.1 Upstream-Downstream
- 8.5.3.2 Gradient Monitoring Design
- 8.5.3.3 Reference Condition Design
- 8.5.4 Exposure Assessment
- 8.5.4.1 Data Collection
- 8.5.4.2 Comparison to Chemical Guidelines
- 8.5.4.3 Mercury Biomagnification
- 8.5.4.4 Environmental Fate
- 8.5.5 Effects Assessment
- 8.5.5.1 Bioavailability
- 8.5.5.2 Toxicity Testing
- 8.5.5.3 Resident Community Structure Alteration
- 8.5.5.4 Investigation of Causation
- 8.5.5.5 The Value of Integrated Assessments
- 8.5.6 Risk Characterisation
- 8.5.7 Uncertainty
- 8.5.8 Monitoring and Management
- 8.5.1 Implementation Considerations
- 8.6 Monitoring Specifics
- 8.6.1 Sampling
- 8.6.2 Analysis
- 8.6.3 QAQC Considerations
- 8.6.3.1 Data Generation and Acquisition
- 8.6.3.2 Data Management
- 8.6.3.3 Data Verification, Validation and Usability
- 8.6.3.4 Performance Assessment and Oversight
- 8.7 ARD Monitoring FAQ's
- 8.8 References